Processing

Please wait...

Settings

Settings

Goto Application

1. WO2020191502 - USE OF EMOXYPINE AND DERIVATIVES THEREOF FOR TREATING KIDNEY DISORDERS AND INFLAMMATORY BOWEL DISEASE

Publication Number WO/2020/191502
Publication Date 01.10.2020
International Application No. PCT/CA2020/050408
International Filing Date 27.03.2020
IPC
A61K 31/44 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
435having six-membered rings with one nitrogen as the only ring hetero atom
44Non-condensed pyridines; Hydrogenated derivatives thereof
A61P 1/00 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
1Drugs for disorders of the alimentary tract or the digestive system
A61P 13/12 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
13Drugs for disorders of the urinary system
12of the kidneys
C07D 213/65 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
213Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
02having three double bonds between ring members or between ring members and non-ring members
04having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
60with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
62Oxygen or sulfur atoms
63One oxygen atom
65attached in position 3 or 5
Applicants
  • ALGERNON PHARMACEUTICALS INC. [CA]/[CA]
Inventors
  • WILLIAMS, Mark
Agents
  • RIDOUT & MAYBEE LLP
  • HELLER, David
Priority Data
62/824,67427.03.2019US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) USE OF EMOXYPINE AND DERIVATIVES THEREOF FOR TREATING KIDNEY DISORDERS AND INFLAMMATORY BOWEL DISEASE
(FR) UTILISATION D'ÉMOXYPINE ET DE SES DÉRIVÉS POUR TRAITER DES TROUBLES RÉNAUX ET UNE MALADIE INTESTINALE INFLAMMATOIRE
Abstract
(EN)
Emoxypine, and derivatives of Emoxypine, are used for the treatment or prophylaxis of renal fibrosis, kidney disease, or chronic kidney disease in a subject. Emoxypine, and derivatives of Emoxypine, are also used for the treatment or prophylaxis of colitis or inflammatory bowel disease in a subject.
(FR)
L'invention concerne l'émoxypine et des dérivés de l'émoxypine, utilisés pour le traitement ou la prophylaxie d'une fibrose rénale, d'une maladie rénale ou d'une maladie rénale chronique chez un sujet. L'émoxypine et des dérivés de l'émoxypine sont également utilisés pour le traitement ou la prophylaxie de la colite ou d'une maladie intestinale inflammatoire chez un sujet.
Latest bibliographic data on file with the International Bureau